Web 2 vs. Web 3 Paths to the Metaverse: Who Is Leading? Who Should Lead?

被引:0
|
作者
Kuai, Le [1 ]
Lacity, Mary [1 ]
Mullins, Jeffrey K. [1 ]
机构
[1] Univ Arkansas, Fayetteville, AR 72701 USA
来源
关键词
Metaverse; Virtual Worlds; Web; 3; Virtual Reality; Platforms;
D O I
10.31585/jbba-6-2-(6)2023
中图分类号
F [经济];
学科分类号
02 ;
摘要
Our research investigates two questions: Who is leading the metaverse? Who should lead? The questions are important because metaverse will have significant consequences for individuals, businesses, and society. We examined the current leaders of metaverse on two evolutionary paths, namely Web 2 and Web 3. Based on regulatory reports, corporate press releases, and patents, we found that only a handful of Web 2 companies are "all-in" on metaverse, and at least one of these enterprises, Meta, is on track to end up as a dominant platform provider. Based on market capitalization, user activity, and patents, only a handful of Web 3 communities are emerging. Despite the hype, we are still in the early days for metaverse on both evolutionary paths. As far as who should lead, we advocate for Web 3 because it benefits more users, content creators, and businesses. However, the future of metaverse is not deterministic and it will emerge from the choices we make today. We offer recommendations on how scholars and companies can support the Web 3 path to the metaverse.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 50 条
  • [41] Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People With Diabetes Who Were Recently Hospitalized
    Wood, Stephen J.
    Bell, J. Simon
    Magliano, Dianna J.
    Shaw, Jonathan E.
    Cesari, Matteo
    Ilomaki, Jenni
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [42] Leadership in Cardiovascular Medicine Twenty-first century medicine should 'listen' to the leadership differences of Akbar vs. Aurangzeb, Emperors who ruled India in the 16th and 17th centuries
    Shaikh, Aaron Ali
    Bhatt, Deepak L.
    Kalra, Ankur
    EUROPEAN HEART JOURNAL, 2019, 40 (18) : 1395 - 1397
  • [44] CHA2DS2-VASc vs. CHADS2 at predicting the risk of stroke and death in a community-based cohort of patients with non-valvular atrial fibrillation who are on anticoagulation
    Yousef Abumuaileq, R. Riziq
    Abu Assi, E.
    Raposeiras Roubin, S.
    Bouzas Cruz, N.
    Lopez Lopez, A.
    Gonzalez Salvado, V.
    Redondo Dieguez, A.
    Gonzalez Ferreiro, R.
    Gonzalez Juanatey, J. R.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1114 - 1114
  • [45] Differences in the Baseline Right Ventricular-Pulmonary Artery Interaction Provides Insight into 'Responders' vs. 'Non-Responders' to PH Specific Therapy in WHO Group 3 Pulmonary Hypertension
    Sinha, S. S.
    Fields, A. V.
    Forfia, P. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S213 - S213
  • [46] Cost-effectiveness analysis of a 3-month exercise program vs. routine follow-up in patients who have completed functional multidisciplinary rehabilitation for low back pain
    Henchoz, Y.
    de Goumoens, P.
    Norberg, M.
    Paillex, R.
    So, A. K. L.
    SWISS MEDICAL WEEKLY, 2009, 139 (31-32) : 6S - 6S
  • [47] Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study
    Jorge E. Cortes
    Qian Jiang
    Jianxiang Wang
    Jianyu Weng
    Huanling Zhu
    Xiaoli Liu
    Andreas Hochhaus
    Dong-Wook Kim
    Jerald Radich
    Michael Savona
    Patricia Martin-Regueira
    Oumar Sy
    Renuka Gurnani
    Giuseppe Saglio
    Leukemia, 2020, 34 : 2064 - 2073
  • [48] Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study
    Cortes, Jorge E.
    Jiang, Qian
    Wang, Jianxiang
    Weng, Jianyu
    Zhu, Huanling
    Liu, Xiaoli
    Hochhaus, Andreas
    Kim, Dong-Wook
    Radich, Jerald
    Savona, Michael
    Martin-Regueira, Patricia
    Sy, Oumar
    Gurnani, Renuka
    Saglio, Giuseppe
    LEUKEMIA, 2020, 34 (08) : 2064 - 2073
  • [49] Brain volume loss after cranial irradiation: a controlled comparison study between photon vs proton radiotherapy for WHO grade 2-3 gliomas
    Gardner, Melissa M.
    Winter, Sebastian F.
    Stahl, Franziska
    Gerstner, Elizabeth R.
    Shih, Helen A.
    Sherman, Janet
    Dietrich, Jorg
    Parsons, Michael W.
    JOURNAL OF NEURO-ONCOLOGY, 2025, 171 (02) : 351 - 363
  • [50] V2O5 vs. LiFePO4: Who is performing better in the 3.4 V class category? A performance evaluation in ?Rocking-chair? configuration with graphite anode
    Praneetha, Selvarasu
    Lee, Yun-Sung
    Aravindan, Vanchiappan
    JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, 2022, 112 : 389 - 397